Depakote
- Product NDC
- 0074-7326
- 11-digit product format
- 000747326
- Labeler code
- 0074
- Product ID
- 0074-7326_7cc3a0b3-93f8-4825-88e1-bf6ddb0db23d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Divalproex Sodium
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Labeler
- AbbVie Inc.
- Application
- NDA018723
- Marketing category
- NDA
- Marketing start
- 2023-06-30
- Substance
- DIVALPROEX SODIUM
- Active strength
- 250 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 644VL95AO6 | DIVALPROEX SODIUM | 76584-70-8 | DIVALPROEX SODIUM |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 0074-7326-13 | 00074732613 | 100 TABLET, DELAYED RELEASE in 1 BOTTLE (0074-7326-13) | 2023-06-30 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Depakote | AbbVie Inc. | 2026-03-31 | HUMAN PRESCRIPTION DRUG LABEL | 1621 |